The Valley Desk

NCT06839456 · Interventional trial

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

Overall registry status Recruiting

Phase 1 · Phase 2

Conditions Acquired Aplastic Anemia, Bone Marrow Failure, HLH, Hemoglobinopathies, High Risk Acute Lymphoblastic Leukemia, High Risk Acute Myeloid Leukemia, Immunodeficiency, Inborn Errors of Metabolism, Inherited BMF Syndrome, Leukemia, MDS (Myelodysplastic Syndrome), Primary Immune Regulatory Disorder, Relapse Leukemia, Relapsed Non-Hodgkin Lymphoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov